|
119 |
Nagai, Michiaki (23498874000); Dote, Keigo (35431564000); Park, Sungha (57992342200); Turana, Yuda (56083326000); Buranakitjaroen, Peera (6603376248); Cheng, Hao-Min (57026688600); Soenarta, Arieska Ann (6507634613); Li, Yan (55931488300); Kario, Kazuomi (7102633390) |
Obstructive sleep apnea and non-dipper: epiphenomena or risks of Alzheimer’s disease?: a review from the HOPE Asia Network |
Hypertension Research |
1 |
Cardiovascular Section, Department of Internal Medicine, Heart Rhythm Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Department of Cardiology, Hiroshima City Asa Hospital, Hiroshima, Japan; Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, South Korea; Department of Neurology, School of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia; Division of Hypertension, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Institute of Public Health and Community Medicine Research Center, National Yang Ming Chiao Tung University School of Medicine, Taipei, Taiwan; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Ph.D. Program of Interdisciplinary Medicine (PIM), National Yang Ming Chiao Tung University College of Medicine, Taipei, Taiwan; Department of Medical Education, Center for Evidence-Based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia; Department of Cardiovascular Medicine, Shanghai Institute of Hypertension Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China; Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan |
Omron Healthcare; Fukuda Denshi; Daiichi-Sankyo |
SP received honoraria from Pfizer, Boryoung, Hanmi, Daewoong, Donga, Celltrion, Servier, Daiichi Sankyo and Daewon. SP also received research grant from Daiichi Sankyo. HMC served as a speaker or member of speakers bureau AstraZeneca; Pfizer Inc.; Bayer AG; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Novartis Pharmaceuticals, Inc.; SERVIER; Co., Pharmaceuticals Corporation; Sanofi; |
Springer Nature |
Q1 |
|
|
